This topic covers AI platforms, models, and agent infrastructures designed to support biodefense and biosecurity use cases, with emphasis on governance, observability, and regulatory compliance. As life‑science workflows become increasingly automated and agentic, organizations need tools that balance capability with auditability, access controls, and threat-mitigation measures. OpenAI’s Rosalind (positioned as a biosecurity‑oriented offering) sits alongside enterprise LLM and agent platforms that supply private models, embeddings, retrieval, multi‑modal reasoning, and orchestrated multi‑agent workflows. Key platform types include: enterprise agent frameworks (Kore.ai) that let teams build and govern multi‑agent workflows with observability and orchestration; agentic AI infrastructure (Xilos) that emphasizes visibility into connected services and agent activity; enterprise LLM stacks (Cohere) offering private, customizable models, embeddings, and retrieval to support secure domain workloads; and multimodal API platforms (Google Gemini) that provide broad generative and perceptual capabilities for complex bioscience tasks. Together these tools address distinct needs: model privacy and customization, secure deployment and access control, activity logging and provenance, and controlled automation via agents. Relevance is driven by accelerating dual‑use risks, increased regulatory attention to AI in biological contexts, and operational requirements for incident investigation and compliance. Practical considerations include deployment topology (on‑prem vs. cloud), evidence trails for decision‑making, policy enforcement across agents, and mechanisms for red‑teaming and safe‑failing. Evaluating platforms for biodefense therefore requires assessing not only raw model performance, but governance primitives, observability, integration boundaries, and vendor controls that reduce misuse risk while enabling legitimate scientific and public‑health work.